Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis (Q45259943)

From Wikidata
Jump to navigation Jump to search
scientific article published in April 2005
edit
Language Label Description Also known as
English
Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis
scientific article published in April 2005

    Statements

    Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis (English)
    Robin Deterding
    George Retsch-Bogart
    Laura Milgram
    Ron Gibson
    Cori Daines
    Bruce Marshall
    Lisa Lavange
    Jean Engels
    Dave Mathews
    Joann Gorden
    Amy Schaberg
    Judy Williams
    Bonnie Ramsey
    Cystic Fibrosis Foundation Therapeutics Development Network
    1 April 2005
    339-348

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit